About Heartsring Medipharma Private Limited
Data last updated:
Heartsring Medipharma Private Limited is a private limited company based in Kanpur, Uttar Pradesh, India. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 18 January 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U33111UP2011PTC043211. Its GSTIN is 09AACCH7088N1ZU (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sandeep Jaiswal and Manish Jaiswal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No. 59 Bima Vihar Lakhanpur, Kanpur, Uttar Pradesh, India – 208024.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.94 Cr, a growth of 19% compared to the previous year. For the same year it recorded a net profit of ₹28.69 Lakh (net margin 3.6%) and EBITDA of ₹47.32 Lakh (EBITDA margin 6%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 10% over five years.
As per MCA filings, the company has open charges of ₹45 Lakh on record. Court records list 1 case involving the company, including 1 filed by the company; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website heartsringpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressH.No. 59 Bima Vihar Lakhanpur, Kanpur, Uttar Pradesh, India – 208024
- IndustryHealthcare, Medical Equipment Retail & Distribution
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Heartsring Medipharma Private Limited
The main business activity of Heartsring Medipharma is trade. In detail, this covers retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Heartsring Medipharma Private Limited FY 2025 filings available
Heartsring Medipharma Private Limited reported revenue of ₹7.94 Cr (up 19% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Heartsring Medipharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 19% growth in the latest year. EBITDA rose 43% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Heartsring Medipharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹47.32 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹28.69 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Heartsring Medipharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 3.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Heartsring Medipharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Heartsring Medipharma Private Limited
Heartsring Medipharma Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cardio-Neuro Devices Private Limited | ₹7.99 Cr (FY 2025) | •••• | •••• | 111.0% | •••• | Delhi, India |
| Unakoti Scientific Private Limited | ₹7.98 Cr (FY 2025) | •••• | •••• | -10.0% | •••• | Kolkata, West Bengal, India |
| Om Meditronics Private Limited | ₹7.97 Cr (FY 2024) | •••• | •••• | 8.0% | •••• | Mumbai, Maharashtra, India |
| E M Technologies India Private Limited | ₹7.97 Cr (FY 2024) | •••• | •••• | -5.0% | •••• | Delhi, India |
| Kochhar Life Sciences Private Limited | ₹7.96 Cr (FY 2025) | •••• | •••• | 30975341.0% | •••• | New Delhi, Delhi, India |
| Heartsring Medipharma Private Limited this company | ₹7.94 Cr (FY 2025) | •••• | •••• | 19.0% | •••• | Kanpur, Uttar Pradesh, India |
| Grace Medtrade Private Limited | ₹7.94 Cr (FY 2025) | •••• | •••• | 23.0% | •••• | New Delhi, Delhi, India |
| Ruvan Medcloud Private Limited | ₹7.94 Cr (FY 2024) | •••• | •••• | 13.0% | •••• | Bangalore, Karnataka, India |
| Anaesthetics India Private Limited | ₹7.92 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Mumbai, Maharashtra, India |
| Seasons Healthcare Limited | ₹7.89 Cr (FY 2025) | •••• | •••• | -80.0% | •••• | Hydrabad, Telangana, India |
| Crest Biologics Private Limited | ₹7.88 Cr (FY 2025) | •••• | •••• | 18.0% | •••• | Bangalore, Karnataka, India |
Peers are the five companies nearest above and the five nearest below Heartsring Medipharma by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Heartsring Medipharma Private Limited
Heartsring Medipharma Private Limited is audited by AJAY M GUPTA & COMPANY for the financial year 2018.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| AJAY M GUPTA & COMPANY | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Heartsring Medipharma Private Limited
Heartsring Medipharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sandeep Jaiswal Also directs: Vedinova Life Sciences Private Limited | Director | 18 Jan 2011 | 15 Years 8 Months | Current |
| Manish Jaiswal Also directs: Vedinova Life Sciences Private Limited | Director | 18 Jan 2011 | 15 Years 8 Months | Current |
Ownership and Shareholding of Heartsring Medipharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Heartsring Medipharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Mar 2015 | State Bank of Patiala | ₹5 Lakh | Open |
| 10 Mar 2015 | State Bank of India | ₹40 Lakh | Open |
Total charge records: 2 View all charges
Legal Cases of Heartsring Medipharma Private Limited
Heartsring Medipharma Private Limited has 1 court case on record: 1 filed by Heartsring Medipharma. All case is pending. Status as checked on 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Kanpur Nagar, Uttar Pradesh | Criminal case | Filed by the company against Shri Sai Enterprises | Pending |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Heartsring Medipharma Private Limited
Employment history and EPFO contributions of people linked to Heartsring Medipharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Heartsring Medipharma Private Limited
Heartsring Medipharma Private Limited has 2 board changes on record since 2011: 2 appointments. The latest: Manish Jaiswal was appointed as Director on 18 Jan 2011.
Credit Ratings, Litigation & Regulatory Alerts for Heartsring Medipharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Heartsring Medipharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Heartsring Medipharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Heartsring Medipharma Private Limited
Heartsring Medipharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AACCH7088N1ZU | Uttar Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Heartsring Medipharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Heartsring Medipharma Private Limited
Heartsring Medipharma is an active private limited company based in Kanpur, Uttar Pradesh, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 18 January 2011 (15+ years old) and is registered under CIN U33111UP2011PTC043211.
Heartsring Medipharma reported revenue of ₹7.94 Cr for FY 2025 (up 19% YoY).
Heartsring Medipharma has 2 current directors:
- Sandeep Jaiswal - Director
- Manish Jaiswal - Director
Heartsring Medipharma reported a net profit of ₹28.69 Lakh (net margin 3.6%) and EBITDA of ₹47.32 Lakh (EBITDA margin 6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Heartsring Medipharma is 10% over three years and 10% over five years. In the latest year (FY 2025) revenue rose 19%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Heartsring Medipharma is 09AACCH7088N1ZU, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Heartsring Medipharma is U33111UP2011PTC043211. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Heartsring Medipharma has 1 court case on record: 1 filed by the company. 1 is pending.
Heartsring Medipharma was incorporated on 18 January 2011, making it 15+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Heartsring Medipharma by revenue are Cardio-Neuro Devices Private Limited, Unakoti Scientific Private Limited, Om Meditronics Private Limited, E M Technologies India Private Limited, Kochhar Life Sciences Private Limited and 5 more, all in the Healthcare industry (Healthcare Equipment Retail and Distribution).
Manish Jaiswal was appointed as Director on 18 Jan 2011. Sandeep Jaiswal was appointed as Director on 18 Jan 2011.